KPIs & Operating Metrics(New)
Growth Metrics

Amgen (AMGN) Enterprise Value Growth (3y) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 27.48%
Dec 31, 2025 0.63%
Sep 30, 2025 6.29%
Jun 30, 2025 -3.78%
Mar 31, 2025 -10.42%
Dec 31, 2024 -14.21%
Sep 30, 2024 11.32%
Jun 30, 2024 -4.79%
Mar 31, 2024 2.78%
Dec 31, 2023 -0.92%
Sep 30, 2023 -41.13%
Jun 30, 2023 -44.20%
Mar 31, 2023 -57.93%
Dec 31, 2022 -1.45%
Sep 30, 2022 18.05%
Jun 30, 2022 30.89%
Mar 31, 2022 37.10%
Dec 31, 2021 35.03%
Sep 30, 2021 24.41%
Jun 30, 2021 34.97%
Mar 31, 2021 31.01%
Dec 31, 2020 36.55%
Sep 30, 2020 33.14%
Jun 30, 2020 33.72%
Mar 31, 2020 40.69%
Dec 31, 2019 38.38%
Sep 30, 2019 18.11%
Jun 30, 2019 14.68%
Mar 31, 2019 8.86%
Dec 31, 2018 2.26%
Sep 30, 2018 1.30%
Jun 30, 2018 0.67%
Mar 31, 2018 -5.86%
Dec 31, 2017 -15.53%
Sep 30, 2017 -13.78%
Jun 30, 2017 -14.42%
Mar 31, 2017 -24.70%
Dec 31, 2016 -25.21%
Sep 30, 2016 -50.41%
Jun 30, 2016 -16.74%
Mar 31, 2016 -17.76%
Dec 31, 2015 -9.26%
Sep 30, 2015 -7.04%
Jun 30, 2015 -72.44%
Mar 31, 2015 -86.11%
Dec 31, 2014 -9.40%
Sep 30, 2014 -7.86%
Jun 30, 2014 -25.63%
Mar 31, 2014 -40.09%
Dec 31, 2013 -2.74%
Sep 30, 2013 1.33%
Jun 30, 2013 -42.51%
Mar 31, 2013 -57.68%
Dec 31, 2012 -16.28%
Sep 30, 2012 -20.60%
Jun 30, 2012 17.59%
Mar 31, 2012 -14.85%